Clinical Trials Logo

Clinical Trial Summary

This is a randomized controlled pilot study aimed at testing different outreach strategies (opt-in versus opt-out) to increase colorectal cancer screening through completion of mailed home fecal immunohistochemical testing (FIT).


Clinical Trial Description

This is a randomized controlled pilot study aimed at testing different outreach strategies to increase colorectal cancer screening using mailed fecal immunohistochemical testing (FIT). The investigators will randomize a cohort of subjects between the ages of 50-74 into 2 arms:

1. Opt-In - subject must actively choose to receive a home FIT kit.

2. Opt-Out - a FIT kit is sent as a default unless the subject actives chooses not to receive the kit or reports prior screening. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02929186
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase N/A
Start date January 2017
Completion date November 15, 2017

See also
  Status Clinical Trial Phase
Completed NCT03068052 - Behavioral Economic Incentives and Cancer Health Risk Assessment N/A
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT05955196 - Test of CD47-SIRPĪ± Inhibitors on the Immune Microenvironment Colon Cancer
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Active, not recruiting NCT05179837 - Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps N/A
Completed NCT02660671 - Behavioral Economic Approaches to Increase Colorectal Cancer Screening N/A
Completed NCT03072095 - Colorectal Cancer Screening in a Community Health Setting N/A